The Claim
Pharmacological inhibition of 15-PGDH increases prostaglandin E2 (PGE2) signaling in muscle stem cells, and this increase is necessary and sufficient to restore proliferation and differentiation of muscle stem cells that are impaired by semaglutide in obese mice.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Blocking the enzyme 15-PGDH raises prostaglandin E2 levels in muscle stem cells of obese mice, and this elevation directly restores the cells' ability to multiply and mature, which semaglutide had suppressed.
See the scientific wording
Pharmacological inhibition of 15-PGDH increases prostaglandin E2 (PGE2) signaling in muscle stem cells, which is necessary and sufficient to restore proliferation and differentiation impaired by semaglutide in obese mice.
When the enzyme that breaks down PGE2 is blocked, PGE2 builds up and binds to receptors on muscle stem cells. This triggers a chain reaction inside the cells that turns on genes needed for them to multiply and turn into new muscle fibers. Semaglutide slows this process by reducing nutrient intake, which puts the stem cells into a deep resting state. Restoring PGE2 signaling overcomes this block and brings back muscle repair.
What the research says
1 studyBlocking the 15-PGDH enzyme helps muscle stem cells recover and grow new muscle fibers, even when semaglutide tries to slow them down. This makes muscles stronger without stopping weight loss.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.